The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of the VENUS study: Bevacizumab efficacy and safety in recurrent, platinum-sensitive ovarian cancer—A real-life ambispective study.
 
Jerome Alexandre
Consulting or Advisory Role - Novartis; Roche; Sanofi
Travel, Accommodations, Expenses - Janssen; Novartis
 
Vincent Launay-Vacher
Honoraria - Amgen; LEO Pharma; Merck; Pierre Fabre; Roche; Takeda; Teva
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Ipsen (Inst); Pierre Fabre (Inst); Roche (Inst)
 
Jean-PHilippe Spano
No Relationships to Disclose
 
Frédéric Selle
Consulting or Advisory Role - MSD; Roche
Travel, Accommodations, Expenses - MSD; PharmaMar; Roche
 
Jean-Baptiste Rey
Honoraria - Kyowa Hakko Kirin; LEO Pharma; Lilly; Roche
Consulting or Advisory Role - LEO Pharma
Travel, Accommodations, Expenses - Kyowa Hakko Kirin; Roche
 
Fabien Brocard
Travel, Accommodations, Expenses - Novartis
 
Anne Floquet
No Relationships to Disclose
 
Claire Garnier-Tixidre
No Relationships to Disclose
 
Claire Giraud
No Relationships to Disclose
 
Jean F. Morere
No Relationships to Disclose
 
Anne Patsouris
Travel, Accommodations, Expenses - Eisai; Novartis
 
Virginie Pottier
No Relationships to Disclose
 
Nadia Raban
No Relationships to Disclose
 
Gilbert Deray
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - Abbvie; Amgen; Pfizer